The purpose of this review is to provide the reader with an up-to-date overview on the biopsychosocial model in cancer pain.
INTRODUCTION
Over half the total number of cancer patients experience cancer-related pain, and many cancer survivors have persistent and ongoing pain as a result of the disease or its treatment [1] [2] [3] [4] . In fact, pain is often described as one of the most troubling aspects of cancer and has a large impact on quality of life among cancer patients [5] . Pain is often a multidimensional experience. The way in which a person experiences and reports pain is influenced by a multitude of factors including aspects of medical illness and treatment, coping, social support, distress, and psychological suffering [6] . The biopsychosocial model is a helpful way to approach comprehensively the conceptualization and treatment of pain in cancer patients at all stages of the disease process.
The biopsychosocial model provides a framework for understanding how diverse biological (e.g., injury, infection), psychological (e.g., negative mood, coping), and social/environmental (e.g., social support, access to services) factors can interact to influence a person's overall experience of pain [7] . As an illustration, negative mood can lead to changes in pain behaviors, such as inactivity, thereby leading to deconditioning in some patients and increasing the body's vulnerability to illness and injury. Pain can also influence mood states. For example, the way in which a person interprets their chronic pain condition (e.g., the degree to which they believe the pain will interfere with daily living) can lead to the development of depression symptoms [8] .
There is considerable research on the biopsychosocial model in cancer pain. Several studies have demonstrated the interplay of biological, psychological, and social factors in the cancer pain experience [6, 7] . More recent research has sought to clarify these interrelations, with a focus on how these factors may vary by diagnosis, treatment, and ,12]. Additionally, research has emerged within the last few years, which has helped to establish an evidence base for certain psychosocial interventions for cancer pain [13 && ]. The purpose of this review is to provide the reader with an up-to-date overview on the biopsychosocial model in cancer pain.
METHOD
This review contains articles published from 2012 to 2014. In this review, we focus on two topics that, we feel, are central to biopsychosocial research in cancer pain: biopsychosocial factors related to the cancer pain experience and psychosocial treatment for cancer pain. The following searches were performed using the OVID database: neoplasm, pain, social support, or quality of life; neoplasm, pain and depression, or anxiety; neoplasm, pain, and psychotherapy or cognitive therapy or behavior therapy. From this search, we identified 34 articles that are included in this review. We selected a subset of articles to highlight in detail in this review, which we felt contributed important findings to these two topics.
RELATIONSHIP OF PSYCHOSOCIAL FACTORS TO CANCER PAIN
Many biopsychosocial factors can influence the cancer pain experience. Aspects of the disease and treatment, coping, support, and psychological suffering can all impact pain and symptom burden. In this section, we review recent research on psycyhosocial factors in cancer pain that highlights these biopsychosocial interrelations.
Psychological symptoms, distress, and pain
It is well established that certain psychosocial factors such as catastrophizing and pain-related anxiety are associated with higher pain levels. [14] . Among cancer patients and cancer survivors, much research has demonstrated the importance of psychosocial factors in the experience of pain. For example, recent research has found associations between higher levels of pain and greater depression [15, 16] , anxiety [17] , distress [18] , and lower quality of life [19] among cancer patients. However, one problem with correlational studies such as these is that they often fail to control for factors such as cancer diagnosis, treatment type, and disease stage, which may relate to both pain and psychosocial variables. More recent research has sought to clarify these complex biopsychosocial interrelations in cancer pain, by controlling for a wide range of medical-and disease-related factors and examining changes in pain and symptom burden longitudinally [9, 10 & ,11 && ,12]. Two recent studies on the development of chronic pain conditions following mastectomy provide greater insight into the biopsychosocial interrelations in cancer pain. These studies suggest that psychosocial factors may help to explain the development of persistent postsurgery pain in breast cancer patients. Belfer et al. [10 & ] found that several psychosocial factors including catastrophizing, somatization, and anxiety were independently related to postmastectomy pain 3 years after surgery. None of the medical and surgical factors examined, such as tumor size and surgical complications, were found to be independently related to postsurgical pain. A similar pattern of findings was found in a study of 611 breast cancer patients [11 && ]. This study found that persistent postmastectomy pain (PPMP) was associated with greater presurgery anxiety, depression, catastrophizing, and somatization, but was not associated with medical and disease-related factors. For example, PPMP was not related to the type of cancer treatment the women received in addition to mastectomy (e.g., radiation, chemotherapy, hormone therapy) [11 && ]. Consistent findings were noted in other recent studies examining predictors of chronic pain following cancer treatment [9, 12] .
Taken together, this research suggests that the development of PPMP in the years following treatment may relate more strongly to psychosocial factors than to treatment and disease-related factors [9, 10 & ,11
]. This is not to suggest that the long-term pain experienced by these breast cancer patients is feigned or exaggerated. Rather, some patients may have psychobiological vulnerabilities for developing chronic painful conditions following surgery. These patients would likely be good candidates for multidisciplinary treatment, beginning at the outset of their cancer care and
KEY POINTS
Recent publications in cancer pain demonstrate that psychosocial factors relate to the development of chronic pain conditions after cancer treatment. Several reviews published within the last 2 years have found modest effect sizes for psychosocial interventions in cancer pain management.
The biopsychosocial model is a helpful way to approach comprehensively the conceptualization and treatment of pain in cancer patients at all stages of the disease process.
continuing posttreatment, in order to more comprehensively address multiple aspects of the symptom burden. Psychosocial interventions for cancer pain will be reviewed later in this article.
Social support
Social support is also an important component of the biopsychosocial model and has been found to relate to symptom burden in cancer patients. A patient's social network provides a source of emotional and tangible support and is especially important during times of crisis, conflict, or stress [20] . There is an established literature demonstrating associations between greater cancer pain and lower levels of social support [21] . Research published within the last 2 years has helped to elucidate these relationships, by examining the specific ways in which social support relates to higher pain in cancer patients. For example, research on cancer patients and their partners suggests that patients with avoidant attachment styles (discomfort with closeness and interdependence in relationships) and anxious attachment styles (worry about the availability and responsiveness of others) are related to patient reports of increased pain and poorer well-being [22, 23] . Other research has focused on caregivers of cancer patients, finding that although caregiver quality of life may not differ by patient disease stage or severity [24, 25] , characteristics of the caregiver, such as having spiritual uncertainty or poor social resources, are related to greater caregiver distress and burden [25, 26] . Given the important role that caregivers can have in patient well-being, it is not surprising that psychosocial interventions, which include caregivers in treatment, were found to result in improved outcomes in the emotional health of both patients and caregivers in a recent review article [27] .
Differences by age
The sections above describe psychological and social factors that relate to the cancer pain experience. Another focus of biopsychosocial research in cancer pain in recent years has been in identifying individual-and disease-related variables, which influence biopsychosocial interrelations. Each patient is unique in their response to cancer and cancer treatment. For example, although certain factors such as depression and anxiety may be associated with greater pain among some cancer patients, this may not be true for others. Identifying individual characteristics that may influence pain and symptom burden will help in better tailoring treatment to each individual patient's needs.
Age may be an important variable in understanding pain experience among cancer patients. Younger cancer patients typically report more pain than older cancer patients [28] . In experimental settings, younger people have been found to have lower thresholds for experimentally manipulated pain [29] . Recent research has suggested that younger patients may also find pain to be more distressing and interfering than older patients. Three studies
&
]. Symptom burden may vary by stage of treatment; a recent study of cancer patients aged 39 and under demonstrated higher distress levels early in treatment and reductions in distress corresponding with ending treatment and returning to activities such as work and school [33] .
Taken together, these studies demonstrate not only that younger cancer patients may experience more pain and other cancer-related symptoms, but that these symptoms may have a greater interference in younger cancer patients' lives. Pain and symptom interference in day-to-day living may contribute to greater mood disturbance and distress among younger people. Further research is needed in order to better understand the cancer pain experience in younger patients. These findings have important implications in treatment of younger cancer patients, who may especially benefit from psychosocial treatment to help with mood and symptom management, changes in physical appearance, life disruption, and adjustment to diagnosis and treatment [34, 35] .
PSYCHOSOCIAL INTERVENTIONS IN CANCER PAIN
The research reviewed thus far suggests that some patients with cancer pain may experience greater distress and psychological symptoms, and poorer social support. These patients may benefit from psychosocial interventions as part of multidisciplinary care. Several empirical studies and review papers have been published in last few years, which have evaluated the strength of evidence for psychosocial interventions in managing multiple aspects of the symptom burden among cancer patients. These reviews cover different types of interventions, represent different theoretical orientations, and target different psychological and physical symptoms in cancer patients. Although not all of the interventions presented in this section were designed to specifically target cancer pain, most examined several cancer symptoms, including pain, as an outcome.
Interventions for pain
Cluster analyses of symptom reporting among cancer patients find that pain often co-occurs with other cancer symptoms [4, 36] . As an example, a recent study of sleep problems in cancer patients found that there was a strong association of sleep difficulties with both pain and emotional distress among patients with active cancer and cancer survivors [37 & ]. Given the co-occurrence of cancer symptoms and known biopsychosocial interrelations in cancer pain, it seems natural that interventions that target one symptom (e.g., pain) may also have a positive effect on other symptoms (e.g., distress). This is consistent with our understanding of the biopsychosocial model. If, for example, a person is experiencing a high degree of distress and anxiety related to cancer pain, then you would expect that treatment aimed to assist the patient in finding ways to cope with and manage the pain would also help to improve the psychological symptoms of distress and anxiety.
Research has emerged in recent years on the effectiveness of psychosocial interventions in managing various aspects of the cancer symptom burden (Table 1 [13   &&   ,38 & , [39] [40] [41] for a summary of research findings). Two recent reviews highlighted here focused specifically on psychosocial intervention studies that assessed pain as an outcome. The reviews included a broad range of interventions such as cognitive-behavioral treatment, relaxation training, and stress management. One meta-analysis found that psychosocial interventions had a moderate treatment effect on pain severity (weighted average effect size 0.34) and pain interference (weighted average effect size 0.40) among patients with heterogeneous cancer diagnoses [13 && ]. Effect size, which refers to the strength of the treatment effect, was calculated in this review by standardizing and pooling effects across studies. A review published in the following year examined the effect of psychosocial interventions on pain outcomes among breast cancer patients and survivors found a similar effect size (g ¼ 0.37) [38 & ]. The authors of both reviews acknowledge that the quality of the studies included in the review vary widely, with some studies demonstrating significant methodological limitations. Another drawback of these reviews is that the effects of a heterogeneous group of interventions were pooled together, making it difficult to tease apart the relative effectiveness of various psychosocial approaches to cancer pain and symptom management. Two reviews published in the last 2 years examined the effectiveness of a unique subset of psychosocial intervention, creative art therapies (CATs). CATs include music therapy, dance/movement therapy, and various forms of art therapy. The mechanisms underlying CAT effects on cancer symptoms are not well understood. Some have proposed that the inherent value of learning a new creative skill, distraction from life stressors, and social support gained from the group atmosphere may underlie treatment effects [42] . A recent metaanalysis found that CAT reduced anxiety, depression, and pain and improved quality of life among cancer patients in active cancer treatment [39] . Importantly, reductions in pain were maintained at posttreatment follow-up. Similarly, music therapy was also found to be an effective form of pain management for cancer patients in a second review [40] .
Differences by stage of disease
Psychosocial interventions have been found to be effective for management of multiple mood and physical symptoms among cancer patients. However, it is important to remember that each patient's psychosocial needs will likely vary by a host of individual-and treatment-related factors. Here, we focus on disease stage. Recent publications have produced some inconsistent findings regarding the effectiveness of psychosocial interventions for pain management among advanced cancer patients. Certainly, some interventions are useful in helping to alleviate mood symptoms and improve quality of life among patients with advanced cancer. Meaningbased and existential therapies have been found to provide benefit on certain outcomes, such as quality of life, among advanced cancer patients [43] . A 2013 Cochrane review of psychotherapy for depression among incurable cancer patients found that nonpharmacologic psychotherapeutic approaches were effective in improving depressive symptomatology [44 & ]. However, there is less support for the use of psychosocial interventions for pain and symptom management in advanced cancer patients. One recent review examined cognitive and behavioral treatments for advanced cancer patients and found little effect for any of the cancer symptom outcomes measured (including pain) [41] . Additionally, a recent study of telephone-based support and medication management among cancer patients found that patients with the most severe baseline pain, and those with disease progression, were less likely to have improvements in pain following treatment [45] . Advanced cancer patients are likely to have a very different pain and symptom profile from cancer patients at other stages of disease. Thus, the role of psychosocial interventions at end of life should be to address the patient's overall suffering through meaning-based, supportive, and other related psychotherapies.
CONCLUSION
There is a large body of literature on biopsychosocial factors in cancer pain and recent publications on the topic advance our understanding in several important ways. Cross-sectional research has consistently found that many factors including greater depression [15] , anxiety [17] , distress [18] , and lower quality of life [19] are correlated with greater pain levels among cancer patients. Recent publications have expanded on this research by examining how psychosocial factors relate to the development of chronic pain conditions after cancer treatment. These findings underscore the importance of multidisciplinary treatment throughout the treatment process to address multiple aspects of the symptom burden. Recent publications have also advanced our understanding of psychosocial interventions for cancer pain and symptom management. Many psychosocial interventions have been found to be effective in managing multiple aspects of the symptom burden including pain, depression, anxiety, and distress. In the last few years, several reviews have emerged, which have found modest effect sizes for psychosocial interventions in cancer pain management. What is less clear is what components of these treatments are most effective (e.g., relaxation, mindfulness).
Future research should continue to examine how different types of treatments work for different groups of patients. Research on individual differences in cancer pain has helped to identify certain patients (i.e. younger patients), who may need a greater level of support. Recent reviews of psychosocial interventions for pain management also suggest that effectiveness may vary by factors such as disease stage. We currently have an established base of research on the importance of biopsychosocial model in cancer pain. What is needed in future research is a greater focus on mechanisms in biopsychosocial interrelations and individual differences in the cancer pain experience. Our ability to treat patients with cancer pain effectively will improve as we gain a better understanding of which treatments work for which patients.
